Skip to main content
Log in

Sneaky Entry of IFNγ Through Arsenic-Induced Leaky Blood–Brain Barrier Reduces CD200 Expression by Microglial pro-Inflammatory Cytokine

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

A Correction to this article was published on 02 August 2018

This article has been updated

Abstract

Recent studies showed that neuronal surface protein CD200 plays a key role in the regulation of neuroinflammation. Previously, we showed that arsenic (0.38 mg/kg body weight) exposure induces microglial activation and consequently IL-6/TNF-α secretion. This result indicated the possibility of alteration in the expression of CD200. Therefore, the present study was focused on checking arsenic-induced alteration in CD200 expression and revealing the underlying mechanism. Male BALB/c mice were exposed to arsenic (vehicle, 0.038 and 0.38 mg/kg body weight) for 60 days, and the expression level of CD200 was found to be decreased which was rescued by minocycline (33 mg/kg body weight) co-administration. Higher CD68 staining, increased level of IL-6/TNF-α, as well as higher level of IFNγ, were observed in in vivo arsenic-exposed groups. Interestingly, in vitro arsenic exposure could not increase IL-6/TNF-α level in the culture supernatant, whereas, supplementation of IFNγ could mimic the in vivo results. However, arsenic could not induce IFNγ production from brain endothelial cells, microglia, and astrocytes, thereby suggesting the entry of IFNγ through the impaired blood–brain barrier. Evans blue fluorescence in the brain confirms altered blood–brain barrier permeability although no changes were observed in the expression level of tight junction proteins (claudin-5 and occludin). Finally, intracerebral injection of anti-IFNγ neutralizing antibody in arsenic-exposed brain reduced microglia activation (IL-6 and TNF-α and CD68 expression) and subsequently rescued CD200 level. Taken together, the study showed that arsenic-mediated compromised blood–brain barrier is a major driving force to induce microglial IL-6 and TNF-α production through serum IFNγ leading to CD200 downregulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Change history

  • 02 August 2018

    The original version of this article unfortunately contained mistake on Fig. 3A.

References

  1. Dentesano G, Serratosa J, Tusell JM, Ramón P, Valente T, Saura J, Solà C (2014) CD200R1 and CD200 expression are regulated by PPAR-γ in activated glial cells. Glia 62(6):982–998

    Article  Google Scholar 

  2. Walker DG, Dalsing-Hernandez JE, Campbell NA, Lue L-F (2009) Decreased expression of CD200 and CD200 receptor in Alzheimer’s disease: a potential mechanism leading to chronic inflammation. Exp Neurol 215(1):5–19

    Article  CAS  Google Scholar 

  3. Zhang S, Wang X-J, Tian L-P, Pan J, Lu G-Q, Zhang Y-J, Ding J-Q, Chen S-D (2011) CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson’s disease. J Neuroinflammation 8(1):154. https://doi.org/10.1186/1742-2094-8-154

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sun F-J, Zhang C-Q, Chen X, Wei Y-J, Li S, Liu S-Y, He J-J, Guo W et al (2016) Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex. J Neuroinflammation 13(1):85

    Article  Google Scholar 

  5. Denieffe S, Kelly RJ, McDonald C, Lyons A, Lynch MA (2013) Classical activation of microglia in CD200-deficient mice is a consequence of blood brain barrier permeability and infiltration of peripheral cells. Brain Behav Immun 34:86–97

    Article  CAS  Google Scholar 

  6. Chitnis T, Imitola J, Wang Y, Elyaman W, Chawla P, Sharuk M, Raddassi K, Bronson RT et al (2007) Elevated neuronal expression of CD200 protects Wld s mice from inflammation-mediated neurodegeneration. Am J Pathol 170(5):1695–1712

    Article  CAS  Google Scholar 

  7. Cox FF, Carney D, Miller A-M, Lynch MA (2012) CD200 fusion protein decreases microglial activation in the hippocampus of aged rats. Brain Behav Immun 26(5):789–796

    Article  CAS  Google Scholar 

  8. Lyons A, Downer EJ, Crotty S, Nolan YM, Mills KH, Lynch MA (2007) CD200 ligand–receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4. J Neurosci 27(31):8309–8313

    Article  CAS  Google Scholar 

  9. Lyons A, McQuillan K, Deighan BF, O’Reilly J-A, Downer EJ, Murphy AC, Watson M, Piazza A et al (2009) Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide. Brain Behav Immun 23(7):1020–1027

    Article  CAS  Google Scholar 

  10. Rosenblum MD, Olasz E, Woodliff JE, Johnson BD, Konkol MC, Gerber KA, Orentas RJ, Sandford G et al (2004) CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. Blood 103(7):2691–2698

    Article  CAS  Google Scholar 

  11. Chen Z, Marsden PA, Gorczynski RM (2006) Cloning and characterization of the human CD200 promoter region. Mol Immunol 43(6):579–587

    Article  CAS  Google Scholar 

  12. Singh V, Gera R, Kushwaha R, Sharma AK, Patnaik S, Ghosh D (2016) Hijacking microglial glutathione by inorganic arsenic impels bystander death of immature neurons through extracellular cystine/glutamate imbalance. Sci Rep 6:30601

    Article  CAS  Google Scholar 

  13. Gera R, Singh V, Mitra S, Sharma AK, Singh A, Dasgupta A, Singh D, Kumar M et al (2017) Arsenic exposure impels CD4 commitment in thymus and suppress T cell cytokine secretion by increasing regulatory T cells. Sci Rep 7(1):7140

    Article  Google Scholar 

  14. Rai A, Maurya SK, Khare P, Srivastava A, Bandyopadhyay S (2010) Characterization of developmental neurotoxicity of As, Cd, and Pb mixture: Synergistic action of metal mixture in glial and neuronal functions. Toxicol Sci 118(2):586–601

    Article  CAS  Google Scholar 

  15. Singh V, Mitra S, Sharma AK, Gera R, Ghosh D (2014) Isolation and characterization of microglia from adult mouse brain: selected applications for ex vivo evaluation of immunotoxicological alterations following in vivo xenobiotic exposure. Chem Res Toxicol 27(5):895–903

    Article  CAS  Google Scholar 

  16. Tyler CR, Allan AM (2014) The effects of arsenic exposure on neurological and cognitive dysfunction in human and rodent studies: a review. Curr Environ Health Rep 1(2):132–147

    Article  Google Scholar 

  17. Kobayashi K, Imagama S, Ohgomori T, Hirano K, Uchimura K, Sakamoto K, Hirakawa A, Takeuchi H et al (2013) Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis 4(3):e525

    Article  CAS  Google Scholar 

  18. Saura J, Tusell JM, Serratosa J (2003) High-yield isolation of murine microglia by mild trypsinization. Glia 44(3):183–189

    Article  Google Scholar 

  19. Pardo B, Contreras L, Serrano A, Ramos M, Kobayashi K, Iijima M, Saheki T, Satrústegui J (2006) Essential role of aralar in the transduction of small Ca+ signals to neuronal mitochondria. J Biol Chem 281(2):1039–1047

    Article  CAS  Google Scholar 

  20. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72(1):248–254

    Article  CAS  Google Scholar 

  21. Gasche Y, Copin J-C, Sugawara T, Fujimura M, Chan PH (2001) Matrix metalloproteinase inhibition prevents oxidative stress-associated blood–brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 21(12):1393–1400

    Article  CAS  Google Scholar 

  22. Paxinos G (2013) Paxinos and Franklin’s the mouse brain in stereotaxic coordinates. Elsevier/Academic Press, Boston

    Google Scholar 

  23. Colaianna M, Tucci P, Zotti M, Morgese M, Schiavone S, Govoni S, Cuomo V, Trabace L (2010) Soluble βamyloid1-42: a critical player in producing behavioural and biochemical changes evoking depressive-related state? Br J Pharmacol 159(8):1704–1715

    Article  CAS  Google Scholar 

  24. Gharibzadeh S, Hoseini SS (2008) Arsenic exposure may be a risk factor for Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 20(4):501–501

    Article  Google Scholar 

  25. Ashok A, Rai NK, Tripathi S, Bandyopadhyay S (2014) Exposure to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats. Toxicol Sci 143(1):64–80

    Article  Google Scholar 

  26. Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T et al (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14(4):388–405

    Article  CAS  Google Scholar 

  27. Liu M-C, Liu X-Q, Wang W, Shen X-F, Che H-L, Guo Y-Y, Zhao M-G, Chen J-Y et al (2012) Involvement of microglia activation in the lead induced long-term potentiation impairment. PLoS One 7(8):e43924

    Article  CAS  Google Scholar 

  28. Zhao F, Cai T, Liu M, Zheng G, Luo W, Chen J (2008) Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicol Sci 107(1):156–164

    Article  Google Scholar 

  29. Kauppinen TM, Higashi Y, Suh SW, Escartin C, Nagasawa K, Swanson RA (2008) Zinc triggers microglial activation. J Neurosci 28(22):5827–5835

    Article  CAS  Google Scholar 

  30. Mishra MK, Basu A (2008) Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J Neurochem 105(5):1582–1595

    Article  CAS  Google Scholar 

  31. Pan W, Banks WA, Kastin AJ (1997) Permeability of the blood–brain and blood–spinal cord barriers to interferons. J Neuroimmunol 76(1):105–111

    Article  CAS  Google Scholar 

  32. Sherwood CL, Liguori AE, Olsen CE, Lantz RC, Burgess JL, Boitano S (2013) Arsenic compromises conducting airway epithelial barrier properties in primary mouse and immortalized human cell cultures. PLoS One 8(12):e82970

    Article  Google Scholar 

  33. Cheng T-J, Ke D-S, Guo H-R (2010) The association between arsenic exposure from drinking water and cerebrovascular disease mortality in Taiwan. Water Res 44(19):5770–5776

    Article  CAS  Google Scholar 

Download references

Funding

This work was supported by CSIR-12th 5-year network project, INDEPTH (BSC001) (CSIR, Council of Scientific and Industrial Research). V.S and J.M were supported by CSIR Senior Research Fellowship. R.G, J.D, and J.A.A were supported by UGC-Senior Research Fellowship, respectively. S.K was supported by CSIR Junior Research Fellowship. The CSIR-IITR manuscript number is 3528.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Debabrata Ghosh.

Ethics declarations

Competing Interests

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, V., Kushwaha, S., Gera, R. et al. Sneaky Entry of IFNγ Through Arsenic-Induced Leaky Blood–Brain Barrier Reduces CD200 Expression by Microglial pro-Inflammatory Cytokine. Mol Neurobiol 56, 1488–1499 (2019). https://doi.org/10.1007/s12035-018-1155-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-018-1155-0

Keywords

Navigation